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Overcoming limitations of tuberculosis information systems: 
researcher and clinician perspectives
Y. F. van der Heijden,1,2 J. Hughes,3 D. W. Dowdy,4 E. Streicher,5 V. Chihota,6,7 K. R. Jacobson,8  
R. Warren,5 G. Theron5
Despite diagnostic innovations, improved access to new and repurposed medications, and efforts to 
shorten treatment duration, tuberculosis (TB) remains 
the leading infectious cause of death worldwide.1 
Many care providers and researchers in high TB burden 
settings give vivid accounts of how flawed patient 
medical record data impair their ability to provide high- 
quality care and make an impact. These limitations un-
dermine advances made in the global fight to end TB.2 
Reliable, integrated data systems would improve pa-
tient care, readily expose gaps in the care cascade, and 
enhance research based on programmatic data.
The World Health Organization (WHO) End TB 
Strategy stresses the importance of strong data systems 
via coordinated, context-specific approaches that pri-
oritize the use and improvement of existing systems 
where possible.2,3 In our experience, however, existing 
data structures and systems are inadequate and chron-
ically underfunded, with limitations that are fre-
quently not readily apparent to patients, providers, 
and researchers. Although many studies assess the per-
formance of diagnostic tests or clinical guideline im-
plementation, few evaluate TB data quality, and we 
are unaware of broader surveys of the impact of poor 
quality data. We surveyed TB researchers and care pro-
viders in high TB burden countries and present those 
results in the context of our clinical and research ex-
periences. We propose a multilevel approach to im-
prove systems for the benefit of patients, public health 
programs, and biomedical research.
METHODS
Our experiences are primarily from South Africa, 
which has a disproportionately high TB burden de-
spite its wealth relative to other high TB burden coun-
tries. To synthesize experiences across a range of set-
tings, we conducted a survey of TB care providers and 
researchers on their experiences with data systems in 
high TB burden countries.1 We searched PubMed for 
TB-related publications from the WHO-designated 30 
high TB burden countries1 by country of institutional 
affiliation and/or conduct of research between Sep-
tember 2011 and September 2016. The Supplementary 
Data includes search terms and the number of individ-
uals identified by search results per country (Supple-
mentary Table S1).
We emailed REDCap4 surveys to at least 20 of the 
most frequently published authors of TB-related En-
glish language publications. We included those whose 
email addresses were available by PubMed, publica-
tion, or institutional website searches. We sent four 
follow-up email reminders as needed. For countries 
from which no invitees responded, we sent additional 
invitations to other co-authors in an attempt to opti-
mize representation from high TB burden countries. 
We tabulated the survey results and reviewed the free-
text comments. We used survey results and consulta-
tion with colleagues involved in TB clinical care and 




We sent surveys to 697 individuals and received re-
sponses from 135 (19%) individuals. Forty-three were 
involved in TB clinical care in the previous 10 years, 
125 were involved in research in a WHO high TB bur-
den country in the previous 10 years, and 42 did both 
(Figure 1). Supplementary Table S2 provides further re-
spondent details.
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Setting: Tuberculosis (TB) diagnosis and treatment re-
quires patients to have multiple encounters with health 
care systems and the different stakeholders who play a 
role in curing them to coordinate their efforts. To opti-
mize this process, high-quality, readily available data are 
required. Data systems to facilitate these linkages are a 
neglected priority which, if weak, fundamentally under-
mine TB control interventions.
Objective: To describe lessons learnt from the use of 
programmatic data for TB patient care and research.
Design: We did a survey of researcher and clinical pro-
vider experiences with information systems and devel-
oped a tiered approach to addressing frequently reported 
barriers to high-quality care.
Results: Unreliable linkages, incomplete data, lack of a 
reliable unique patient identifier, and lack of data man-
agement expertise were the most important data-related 
barriers to high-quality patient care and research. We 
propose the creation of health service delivery environ-
ments that facilitate, prioritize, and evaluate high-quality 
data entry during patient or specimen registration.
Conclusion: An integrated approach, focused on 
high-quality data, and centered on unique patient identi-
fication will form the foundation for linkages across 
health systems that reduce patient management errors, 
bolster surveillance, and enhance the quality of research 
based on programmatic data.
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Responses regarding clinical care
When asked to name the single most important da-
ta-related barrier to excellent TB care, most respon-
dents identified unreliable data linkage among clinics, 
hospitals, and laboratories (17/43, 40%), followed by 
lack of expertise for managing or retrieving data 
(10/43, 23%), lack of a reliable unique patient identi-
fier (5/43, 12%), incomplete data (5/43, 12%), and un-
reliable data (3/43, 7%) (Supplementary Table S3). Fur-
thermore, 20/43 (47%) of the respondents stated that 
errors in linking programmatic data across informa-
tion systems had led to errors in patient care, while 
15/43 (35%) cited incorrect matching of unique pa-
tient information as leading to similar errors.
Responses regarding research
Over one half of the researchers who responded re-
ported that data limitations had hindered research ad-
vances. Within the domain of information systems, re-
searchers identified incomplete data (38/125, 30%), 
unreliable data linkage (27/125, 22%), and lack of a re-
liable unique patient identifier (26/125, 21%) as the 
top three most important research-related barriers 
(Supplementary Table S4).
With regard to unreliable data linkage and unique 
patient identifiers, 73/125 (58%) respondents involved 
in research had observed incorrect patient matching, 
and 32/125 (26%) reported that patient matching er-
rors caused significant problems or delays in research. 
Several respondents noted that poor data linkages 
from laboratories to treatment facilities caused delays 
in receiving critical test results, resulting in delayed or 
incorrect treatment. Furthermore, respondents noted 
that patients who are transferred to different facilities 
often do not bring their records with them, which can 
be difficult to recover from referring facilities. Table 1 
provides additional examples of patient care errors due 
to data system limitations drawn from our experience 
with consequences that included prolonged potential 
for TB transmission, side effects such as deafness, and 
incorrect treatment.
The use of a medical record number as a unique 
identifier did not always mitigate errors related to data 
linkage; of the researchers who reported exclusive use 
of a unique identifier at a health facility or laboratory 
(rather than methods such as patient name and date of 
birth), 28% noted matching errors with adverse conse-
quences (e.g., persistent duplications, difficulty follow-
ing patients through the care cascade). When asked 
who was responsible for verifying whether patients 
have been previously assigned a unique identifier, 74% 
of researchers did not respond. The complete survey 
results can be viewed in the Supplementary Data (Sup-
plementary Tables S2–S4).
Framework for tuberculosis data
Based on the survey results and our experience, we de-
veloped a framework for understanding and address-
ing TB-related data concerns. Figure 2 shows the levels 
of TB data systems integration according to their po-
tential programmatic scale and impact and the antici-
pated general ease of implementation. Figure 3 shows 
how systems that reliably identify and distinguish 
each patient permit tracing individuals from screening 
to treatment completion and disease recurrence. Data 
fields that should be captured in routine TB data sys-
tems may vary per setting, but Supplementary Table S5 
includes important data fields based on our survey and 
experience.
DISCUSSION
The survey respondents highlighted the urgent need 
to strengthen TB data systems. We discuss the themes 
that emerged from the survey and from our experience 
below.
The fundamental challenge of patient 
identification
Reliable identification of a patient’s relevant clinical 
history, whether at one or more sites, is critical for in-
dividual care, public health, and research purposes 
(Figure 2). Correct patient identification can occur 
ACKNOWLEDGEMENTS
The authors thank K Clouse, 
R Dunbar, and A Garcia-Prats 
for feedback on a pilot 
survey, and H Cox for critical 
review of the manuscript.
This work was supported by 
the National Institute of 
Allergy and Infectious 
Diseases at the National 
Institutes of Health 
(Bethesda, MD, USA; grants 
K08-AI106420 and 
R01-AI119037); the National 
Center for Advancing 
Translational Sciences 
(Bethesda, MD, USA; UL1 
TR002243); the National 
Research Foundation of 
South Africa and the 
National Research 
Foundation of South Africa 
Research Career 
Advancement Award 
(Pretoria, South Africa); the 
South African Medical 
Research Council (Cape 
Town, South Africa; SAMRC-
RFA-IFSP-01-2013/BAR-TB); 
the European and 
Developing Countries 
Clinical Trial Partnership (The 
Hague, Netherlands; 
SF1041); and the Faculty of 
Medicine and Health 
Sciences, Stellenbosch 
University (Cape Town, 
South Africa). 
The funders of the study had 
no role in any aspect 
pertinent to the work, 
including design, survey, 
analysis, or writing of the 
article. The content is solely 
the responsibility of the 
authors and does not 
necessarily represent the 
official views of the funders.
Conflicts of interest: none 
declared.
FIGURE 1 Flow diagram of survey distribution and responses. TB = 
tuberculosis.
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through consistent use of information such as names and date of 
birth, or through a properly assigned unique patient identifier 
such as a clinic medical record number or a national health iden-
tifier. As suggested by our survey, problems with record duplica-
tion and incorrect linkage may persist if unique identifiers are not 
carefully assigned. Although unique patient identification is criti-
cal, it is not a panacea.
The WHO and the Joint United Nations Programme on HIV/
AIDS (UNAIDS) provide detailed guidance for the implementation 
of national health identifiers, including in resource-limited coun-
tries.5,6 In countries where a national health identifier is not feasi-
ble, a commitment to high-quality data capture that informs a 
standardized approach to TB patient identification at all points of 
contact forms the basis of reliable data linkages. Ensuring the reli-
ability of local data with consistent monitoring, evaluation, and 
planning should be prioritized in all settings.7
Biometric data from fingerprints, iris, palm, face, or voice rec-
ognition can mitigate the need for patients to present an identifi-
cation card, remember an identification number, or provide con-
sistent identifying information. A platform using fingerprint 
recognition on tablets was implemented in a rural setting in 
Uganda.8 This provided health workers with immediate feedback 
regarding treatment adherence and led to improvements in loss 
to follow-up and patient outcomes. The optimal biometric modal-
ity in high-burden populations needs further study with respect 
to cost, scalability, and data storage and retrieval processes, as 
well as security, ethics, and stigma.9
Access to patient data at a health facility
Providers ideally have access to an individual’s medical history 
when diagnosing and treating TB (Figure 2). Individuals are at 
times assigned multiple different medical record numbers within 
the same system, whether at a clinic, hospital, laboratory, or in a 
TB register (Table 1). Single-site patient identification errors are 
prone to occur in high-burden settings, particularly when workers 
lack resources or are not adequately trained in the importance of 
accurate data capture. Other factors, such as illegible handwriting, 
keystroke errors in electronic records, and omission of data fields 
are broadly applicable (Table 2). Since many errors occur at pa-
tient registration, emphasis on improving systematic patient 
TABLE 1 Examples of errors in patient care related to data limitations reported by clinicians in Western Cape Province, South Africa. A 
hypothetical example demonstrates the positive impact of improved data systems
Real-world examples arising from limited data systems
 While evaluating patient outcomes in a densely populated informal settlement near Cape Town, South Africa, care providers found that one patient 
had been assigned more than three medical record numbers in the same care system and seven laboratory registration numbers due to inaccurate 
capture of personal information. The duplications likely occurred due to varied spellings and ordering of first names and surnames. It was then 
administratively easier to create a new identity number in the systems rather than check in detail for existing numbers. The errors were only noticed 
when an epidemiologist took the time late in the patient’s care to figure out the patient’s entire TB-related history
 A female aged 18 years was diagnosed with rifampicin-resistant TB using Xpert® MTB/RIF and started on what was, at the time, the standard MDR-TB 
treatment regimen that included kanamycin. An audiogram reported hearing loss, so kanamycin was stopped without plans to restart it. She was 
subsequently admitted to the district hospital, where her previous TB laboratory results were found in the laboratory database, but her treatment 
records were not identified. Based on her Xpert results, she was started again on a regimen including kanamycin, and subsequently developed 
deafness. Her initial MDR-TB treatment records were later found under a different medical folder number. If the doctors at the district hospital had 
all treatment records available under a single medical record number, irreversible hearing loss could have been prevented
 A male patient aged 24 years undergoing treatment for MDR-TB at a TB clinic was admitted emergently over a weekend to a nearby hospital intensive 
care unit for pneumonia. The patient told the doctor in the hospital that he had been previously cured of drug-susceptible TB, but did not inform 
the doctor that he had recently started MDR-TB treatment. The patient had multiple medical record numbers, and his recently positive sputum 
results were listed under a different medical record number than the one available to the hospital doctor. Furthermore, the doctor did not have 
access to the TB clinic records and so was not aware that the patient still posed an infectious risk to others in the hospital. Three additional patients 
(including a baby) in the closed ward were subsequently exposed to MDR-TB. When the patient did not improve clinically after several days, 
hospital staff started calling local clinics. The clinic staff who answered the call from the hospital recognized his name, and his MDR-TB treatment 
records were identified. If the patient had not had duplicate medical record numbers and if his TB treatment details had been linked and available 
to the hospital doctors, the interruption of the patient’s treatment and exposure of other patients could have been avoided
A hypothetical example from a setting with strengthened data systems, and how these improvements can positively impact different domains
 A recent migrant is screened for symptoms and tested for TB. He thinks he had a TB diagnosis before but is unsure if it was drug-resistant. His latest 
Xpert is positive for rifampicin-resistant Mycobacterium tuberculosis. By scanning his unique patient identifier, the clinical provider learns that the 
patient was on MDR-TB treatment a year ago, but subsequently recorded as lost to follow-up. Therefore, the clinical provider requests second-line 
drug susceptibility testing, and results demonstrate pre-XDR-TB. Based on this, and his prior exposure to pyrazinamide and ethambutol 
(documented in linked records), he is started on an individualized regimen containing bedaquiline. In a few months, he plans to return home, 
where his family can support him. The clinic in his hometown is able to import his recent history easily and his treatment can continue 
uninterrupted
Patient care
 The patient’s unique identifier ensures that his records are complete
 The patient’s records are linked across compatible systems that allow TB care providers in different regions access to previous treatment and 
laboratory records
 Optimal laboratory testing and treatment regimens can be selected without unnecessary delays or duplication of efforts
Public health
 The patient’s movement is able to be reported (allows resource allocation)
 The patient’s return to care after being considered lost to follow up is identified (ensures appropriate surveillance reporting)
 Optimal use of healthcare resources (expedites program evaluation)
Research
 Programmatic data can be used due to correctly linked laboratory and treatment data across a region over time
 Research involving TB transmission, outcomes, drug resistance, and process evaluation can potentially be conducted
TB = tuberculosis; MDR-TB = multidrug-resistant tuberculosis; XDR-TB = extensively drug-resistant tuberculosis.
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identification strategies at registration would help minimize du-
plication of patient records and false linking of data (Table 3).10
The WHO has provided guidance for standardized recording 
and reporting of TB data for decades, with updates, tools, and 
technical recommendations for data quality assessments that can 
be implemented at health facilities.11–14 These recommendations 
are primarily concerned with improved data reporting, but fur-
ther guidance for establishing and maintaining high-quality data 
for clinical care and research may be beneficial. Furthermore, fac-
tors such as data validation, supervision of staff, and monitoring 
of data systems rely on funding, availability, and program prioriti-
zation of data quality. Data validation should consist of checks 
for internal consistency, completeness of essential fields, and veri-
fication of correctly linked data. Supervision should include 
demonstration of support for data quality assurance at all levels, 
including from TB program administrators, and involve appropri-
ate training and supervision of protected time for data capture 
and data quality work. Resources should be allocated for installa-
tion and maintenance of relevant monitoring systems that rou-
tinely assess whether reported TB cases at the program level are 
consistent with individual patient data, patterns of data omis-
sions and duplications, and gaps in the program diagnostic and 
treatment cascades.
Integrated tuberculosis laboratory and health facility data 
systems
Health care facilities, laboratories, pharmacies, and registries ide-
ally are integrated to allow immediate and consistent updates to 
patient information accessible at the point of care (Figure 2). Data 
systems that leverage standardized, automated technologies or 
procedures and ensure compatible data formats will minimize 
linkage errors, thereby contributing to better patient care and 
outcomes while eliminating wasted resources on duplicate tests. 
Supplementary Table S6 lists several factors that contribute to 
data errors between sites, and potential solutions. Most patient 
data sources represent ‘silos’ of information; they are either in-
trinsically limited to a single site (e.g., paper charts at a clinic), or 
they have not been designed to link with others. Table 1 describes 
the ideal components of a data system to support TB patient care.
Population migration is a particularly challenging aspect of 
data systems for TB. Substantial movement occurs in TB-endemic 
regions due to employment opportunities, political instability, 
family visits, and cultural customs.15,16 Patients may also present 
to different treatment facilities within the same region due to 
transportation difficulties, stigma associated with the diagnosis of 
TB, or perceptions of care at a facility.17
Electronic information systems that can be monitored and 
evaluated for internal data quality and linkage with other systems 
are invaluable for the longitudinal care of TB patients.18–20 For ex-
ample, the Global Laboratory Initiative provides guidance for in-
frastructure development linking diagnostic information to TB 
programs, potentially allowing seamless and immediate transfer 
of laboratory results with care providers and electronic registers, 
along with capacity for data quality monitoring.21
Cross-regional and national databases
Reliably and immediately linked laboratory and TB treatment 
data can be used to populate registers that inform targeted inter-
ventions at programmatic levels (Figure 2). Nationally imple-
mented electronic TB treatment registers in South Africa provide 
opportunities for tracking patients, but still face challenges re-
lated to data integrity. For example, only 62% of children with 
culture-confirmed TB at one referral hospital in South Africa from 
2007 to 2009 were registered in the provincial register.22 Incom-
plete, duplicate, or incorrect patient data can introduce bias and 
misrepresent gaps, leading to disordered priorities, misdirected re-
sources, and ultimately, adverse patient outcomes.23,24
Data errors can lead to the over- or under-reporting of TB data, 
which may affect local or national results and global estimates of 
disease. For example, TB deaths recorded in surveillance differed 
FIGURE 2 Multi-level approach to addressing data systems limitations for TB patient care. Levels are orga-
nized according to potential programmatic impact (most impactful at top) and anticipated general ease of 
implementation (most easily implemented at bottom). Ensuring high-quality data for the reliable identifica-
tion of individuals for long-term TB care (Level 1) is a critical foundation for improving data systems. Opti-
mized patient care relies on high quality, complete data entry at the point of service (Level 2), which links 
to other points of service including TB clinics, hospitals, laboratories, and pharmacies (Level 3). Individual 
patient care data then feed into sub-regional, regional, national, and even supranational databases (Level 
4) and can be used to populate interoperable health data on TB, HIV, and non-communicable diseases 
(Level 5). TB = tuberculosis; HIV = human immunodeficiency virus.
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substantially from vital registration systems in England and 
Wales, highlighting the need for improved data capture for na-
tional resource allocation.24
Unified health databases across multiple diseases
Interoperable healthcare data systems that extend beyond TB to 
include regionally significant diseases provide opportunities for 
streamlined care, tailored public health interventions, and broad 
population health assessments (Figure 2). With growing interest 
in comorbidities (e.g., human immunodeficiency virus [HIV] in-
fection, diabetes), unified data systems could facilitate large-scale 
programmatic planning and research through health information 
exchange.25,26
In South Africa, a provincial health information exchange is 
being implemented to provide bi-directional transfer of informa-
tion and immediate access to individual patient and program-
matic data.27 Such approaches for integration of health services 
may be costly and complicated and require context-specific as-
sessments of effectiveness.28
If overall healthcare data systems integration is not feasible 
in high-burden settings, there may still be opportunities for 
linking TB data systems to those of other highly relevant dis-
eases.29 Many of the same data limitations that plague TB also 
affect HIV care,30 and investing in integrated TB-HIV data sys-
tems might improve patient monitoring in regions with high 
rates of HIV co-infection.
Research is critical for improving patient care and public 
health practice. When patients’ treatment history and labora-
tory results are not longitudinally linked, there is an absence of 
data flow between information systems and facilities (Figure 3), 
and critical study outcomes such as TB recurrence, acquisition 
of resistance, or timing of culture conversion may not be cap-
tured accurately. For example, when South Africa introduced 
early bedaquiline access, some pilot sites maintained parallel 
data sets because existing drug-resistant TB registry data had se-
vere backlogs in data entry and bedaquiline-related data fields 
were unavailable. On the other hand, programs such as the 
Structured Operational Research and Training Initiative (SORT 
IT) have been successful in building capacity for policy-chang-
ing operational research while building bridges between TB pro-
gram staff and researchers.31 The use of programmatic data for 
research on the implementation of new technologies and drugs, 
such as Xpert® MTB/RIF (Cepheid, Sunnyvale, CA, USA) for TB 
diagnosis, can provide invaluable guidance to other adopting 
countries.32,33
A way forward
To develop integrated systems with reliable patient data, stake-
holders across disciplines urgently need to invest resources and 
coordinate efforts. Funding for data systems improvement is not 
typically prioritized but is essential. Focused funding calls for sus-
tainable data systems improvements, performance incentives for 
FIGURE 3 Example of TB patient flow and linked information systems from presenta-
tion to a health-care facility to outcome after treatment. The straight arrows represent 
information links, each of which represents opportunities for providing excellent care or 
liabilities for errors in data entry, patient identification, and linkage. Note that patients 
can present at different facilities at each step along the pathway. The curved gray arrow 
denotes that patients can have multiple episodes of care for TB. TB = tuberculosis.
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TABLE 2 Factors that contribute to data errors within a site or system, with examples and potential solutions. Many errors, including 
assignment of multiple incomplete patient records to a single patient and allocation of more than one patient’s data to a single medical record 
number occur at registration. Poor data collection at point of care is thereafter carried forward across linked systems and registries and is much 
easier to prevent or correct at entry than downstream
Factors Examples Potential short-term solutions Potential long-term solutions
Registration information 
entry errors
Staff misunderstand spelling or order of 
patient names, birth date, address
Patients provide inconsistent name 
spelling or order, birth date, address, 
identification number
Staff not familiar with patient name 
pronunciation/spellings or local 
customary naming conventions 
(especially cross-cultural)
Data entry or transcription errors
Standardized patient registration 
protocols that account for cultural 
context of the region (e.g., include 
both married name and maiden 
name in identifiers searched at 
registration)
See Table 3 for other solutions
Create or use existing programs that 
use matching systems based on 
multiple patient identifiers and 
provide staff immediate results of 
partially matching previously 
registered patients if a perfect match 
is not found and a mechanism for 
confirming and merging probable 
matches
Implement unique patient identifiers 
such as identification number or 
biometric identifiers
Foster an environment that facilitates 
and values error reporting instead of 
punitive measures for error reporting 
or poor outcomes
High patient or 
specimen volume
Not enough staff time to verify if 
patient entered in system previously
Incomplete data fields
See Table 3
Flags for mandatory data entry fields
New and improved use of existing 
technologies for efficient TB patient 
or TB laboratory sample registration 
(e.g., barcodes, biometrics)
Insufficient staffing or 
skills
Data capture and quality assurance 
roles not prioritized
Staff given responsibility for data 
without adequate training or support
Poor understanding of importance of 
identifiers and data
Education and training
Support and incentives for excellent 
patient registration, data entry, data 
quality assurance practices
New and refresher curricula for staff: 
importance of data integrity




Flexible work hours for more computer 
access
Funding of data entry and data support 
personnel
Training program managers about data 
quality, necessity of resources for data 
integrity
Patient health literacy Patients may not remember exact 
identification information or previous 
treatment details
Emphasize patient education within 
treatment model, empower TB 
patients to be stewards of their care
Assign patients specific staff members 
for longitudinal care
Community engagement and TB 
education campaigns
Implement a system of patient-held 
clinical notes, to be used at every 
health service interaction
Biometric identification
Intentional data errors Patients falsify identifiers due to stigma, 
fear of identification
Staff alter outcomes due to 
performance incentives or 
administrative expectations, 
demands, or threats
Include performance incentives for staff 
to capture high data quality
Foster a compassionate healthcare 
environment that educates 
healthcare workers on ways to avoid 
stigmatizing patients, e.g., ‘values 
clarification’ workshops
Encourage a culture of transparency 
and error reporting
TB = tuberculosis.
TABLE 3 Strategies for registering TB patients without introducing errors leading to duplication of records or patient misidentification10,34
Observe and evaluate current patient registration systems and flow to determine site-specific performance and sources of patient registration errors
Develop a standardized approach for patient registration which makes assignment of a new medical record number an option of last resort after asking 
patients if they have been registered at the site previously and iterative searches for previous patient records using multiple variations of several 
identifiers
Train all individuals responsible for registering patients in standard procedures with initial and refresher sessions, emphasize the importance of correct 
patient registration for patient care, and assess competency
Review patient registration performance regularly (can be daily), and provide performance feedback to individuals regarding data entry errors, including 
duplications
Use technology to optimize searches for previous patients, including customized probabilistic matching software, to prompt possible matches to master 
patient index and incorporation of patient photographs into medical record for additional verification
Provide access to information technology support staff
Perform regular quality control of the patient registration process in conjunction with evaluation of master patient data for the facility
Ensure that managers and staff know who is responsible for data quality, including assignment and verification of medical record numbers/unique health 
identifiers
TB = tuberculosis.
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TB programs and staff, and motivation for companies to develop 
cost-effective and scalable technologies should be pursued.
Our survey had important limitations, including a low re-
sponse rate and lack of representation from many TB control pro-
grams. We did not specifically target TB program workers, al-
though many TB researchers are actively engaged in 
programmatic work. Participation of TB program staff and man-
agers to assess weaknesses and implement improvements is essen-
tial and will complement the recommendations made here.
CONCLUSION
TB data systems have critical weaknesses in many high-burden 
settings. Unless approaches to improve such systems are imple-
mented now, preventable errors in patient care will continue. Fur-
thermore, program and policy decisions will be supplied with in-
accurate information that could jeopardize the efficient use of 
funds, and answers to important research questions will remain 
inaccessible. Current efforts to improve data limitations require 
substantially increased support from stakeholders, clear strategies 
for performance evaluation, and the use of frameworks for the op-
timization of patient care based on these data systems 
improvements.
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Cadre  :  Le diagnostic et le traitement de la tuberculose (TB) exigent 
des patients de multiples rencontres avec le système de santé et les 
différentes parties prenantes qui jouent un rôle dans leur guérison 
afin de coordonner leurs efforts. Pour que cela se passe au mieux, des 
données de grande qualité facilement disponibles sont requises. Les 
systèmes de données visant à faciliter ces liens sont une priorité 
négligée dont la faiblesse affaiblit intrinsèquement les interventions 
de lutte contre la TB.
Objectif  :  Décrire les leçons apprises à partir de l’utilisation des 
données de programme dans la prise en charge des patients atteints 
de TB et pour la recherche.
Méthode  :  Nous avons réalisé une enquête sur les expériences de 
chercheurs et de cliniciens relatives aux systèmes d’information et 
élaboré une approche progressive pour examiner les obstacles 
fréquemment rapportées à une prise en charge de bonne qualité.
Résultats  :  Des liens non fiables, des données incomplètes, 
l’absence d’un identifiant unique fiable pour chaque patient et le 
manque d’expertise en gestion des données ont été les obstacles 
les plus importants, en termes de données, à une bonne qualité 
de la prise en charge des patients et de la recherche. Nous 
proposons la création d’un environnement de prestation des soins 
de santé qui facilite, priorise et évalue la saisie de données de 
bonne qualité lors de l’enregistrement du patient ou d’un 
échantillon biologique.
Conclusion  :  Une approche intégrée, concentrée sur des données de 
qualité élevée, centrée sur une identification unique de chaque 
patient, constituera la base des liens entre systèmes de santé qui 
réduisent les erreurs de prise en charge des patients, renforcent la 
surveillance et améliorent la qualité de la recherche basée sur les 
données du programme.
Marco de referencia: El diagnóstico de la tuberculosis (TB) y su 
tratamiento exigen contactos múltiples de los pacientes con el sistema 
de atención de salud y los diferentes interesados directos que intervienen 
en su curación a fin de coordinar sus esfuerzos. Una coordinación óptima 
precisa la existencia de datos de gran calidad. El hecho de descuidar la 
prioridad de los sistemas de datos que facilitan estos vínculos, los 
debilitan y socava las intervenciones de control de la TB.
Objetivo: Describir las enseñanzas extraídas de la utilización de los 
datos programáticos en la atención de los pacientes y la investigación 
en materia de TB.
Método: A partir de una encuesta sobre la experiencia de los 
investigadores y los proveedores de atención con los sistemas de 
información, se elaboró un método escalonado con el fin de abordar 
los obstáculos frecuentes referidos en la prestación de una atención 
de buena calidad.
Resultados: Los principales obstáculos relacionados con la buena 
calidad de la atención de salud y la investigación fueron los vínculos 
poco fiables, los datos incompletos, la falta de un número único 
seguro de identificación de los pacientes y la incompetencia en la 
gestión de los datos. Se propone la creación de entornos de 
prestación de servicios de salud que faciliten, den prioridad y evalúen 
el ingreso de datos de buena calidad en el momento del registro del 
paciente o de las muestras.
Conclusión: Un enfoque integrado basado en la calidad de los datos, 
alrededor de un número de identificación único de los pacientes, 
constituirá el cimiento de vínculos entre sistemas de salud que 
promueven la disminución de los errores de manejo de los pacientes, 
el refuerzo de la vigilancia y la promoción de la calidad de la 
investigación basada en los datos programáticos.  
